Status:
COMPLETED
" En Face " OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic Antimalarials
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Maculopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The maculopathy induced by the retinal toxicity of the synthetic antimalarials must be detected at the infra-clinical state, when it can still be reversible. Identifying early retinal anatomical chang...
Eligibility Criteria
Inclusion
- Patients treated with synthetic antimalarials with retinal damage (in relation with the antimalarial treatment) recently diagnosed by mfERG
- Patients treated with synthetic antimalarials in the past, who stopped treatment because of a supposed retinal damage not confirmed by mfERG
Exclusion
- \- State of ocular structures preventing the realization of exams
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT02805686
Start Date
June 1 2014
End Date
February 1 2016
Last Update
January 26 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.